J-Y. Blay - Dept Med, NetSARC | 人才画像

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 42 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Natural history and treatment efficacy in an ambispective case series of NTRK-rearranged mesenchymal tumors

A Dufresne, D Pissaloux,C Ngo, N Penel,A Le Cesne,N Macagno,H Vanacker, C Hénon, M Jean-Denis, K Rughoo,F Tirode,J-Y Blay,

ESMO openno. 2 (2023): 101202-101202

引用0浏览0WOS引用

Synovial sarcoma: characteristics, challenges, and evolving therapeutic strategies

J-Y Blay,M von Mehren,R L Jones, J Martin-Broto, S Stacchiotti,S Bauer, H Gelderblom, D Orbach, N Hindi,A Dei Tos, M Nathenson

ESMO open（2023）

引用0浏览0WOS引用

Early phase trials in soft-tissue sarcomas: clinical benefit of inclusion in early lines of treatment, molecular screening, and histology-driven trials

E F Nassif,J-Y Blay,C Massard,A Dufresne, M Brahmi, P Cassier, I Ray-Coquard,P Pautier,A Leary,M-P Sunyach, R Bahleda,A Levy,

ESMO Open（2022）

引用3浏览0WOS引用

Final analysis of the randomized trial on imatinib as an adjuvant in localized gastrointestinal stromal tumors (GIST) from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG), the Australasian Gastro-Intestinal Trials Group (AGITG), UNICANCER, French Sarcoma Group (FSG), Italian Sarcoma Group (ISG), and Spanish Group for Resear..

P G Casali,A Le Cesne, A P Velasco, D Kotasek,P Rutkowski, P Hohenberger, E Fumagalli, I R Judson, A Italiano,H Gelderblom, N Penel, J T Hartmann,

Annals of oncology : official journal of the European Society for Medical Oncology（2021）

引用31浏览0WOS引用

A randomized phase III trial comparing trabectedin to best supportive care in patients with pre-treated soft tissue sarcoma: T-SAR, a French Sarcoma Group trial

A Le Cesne,J-Y Blay, D Cupissol, A Italiano,C Delcambre, N Penel, N Isambert, C Chevreau, E Bompas, F Bertucci, L Chaigneau,S Piperno-Neumann,

Annals of oncology : official journal of the European Society for Medical Oncology（2021）

引用21浏览0WOS引用

Expression and prognostic significance of PDGF ligands and receptors across soft tissue sarcomas

M Brahmi,T Lesluyes,A Dufresne, M Toulmonde, A Italiano, O Mir,A Le Cesne,T Valentin, C Chevreau,S Bonvalot, N Penel,J-M Coindre,

ESMO Open（2021）

引用7浏览0WOS引用

Programmed cell death 1 (PD-1) targeting in patients with advanced osteosarcomas: results from the PEMBROSARC study

A Le Cesne,P Marec-Berard,J-Y Blay,N Gaspar,F Bertucci,N Penel,E Bompas,S Cousin,M Toulmonde, A Bessede,W H Fridman, C Sautes-Fridman,

European Journal of Cancer（2019）

引用99浏览0WOS引用

Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101 'CREATE'

P Schöffski,A Wozniak,S Stacchiotti,P Rutkowski,J-Y Blay,L H Lindner,S J Strauss,A Anthoney,F Duffaud,S Richter,V Grünwald,M G Leahy,

Annals of Oncology（2019）

引用77浏览0WOS引用

Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

P G Casali, S Bielack, N Abecassis, H T Aro, S Bauer, R Biagini, S Bonvalot, I Boukovinas, J V M G Bovee, B Brennan, T Brodowicz, J M Broto,

Annals of oncology : official journal of the European Society for Medical Oncology (2018)

引用0浏览0WOS引用

Op-anno180096 51..67

P. G. Casali, N. Abecassis, S. Bauer, R. Biagini, S. Bielack, S. Bonvalot, I. Boukovinas, J. V. M. G. Bovee, T. Brodowicz, J. M. Broto, A. Buonadonna,E. De Álava,

semanticscholar（2018）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn